Kopran Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

217.10

-2.39 (-1.09%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

217.10

-2.39 (-1.09%)
16:02 Dec 20

Quality

79/100
High Financial Strength

Valuation

63/100
Affordable Valuation

Technical

38/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	491.81	477.52	550.99	614.59	636
Operating Expenses +	410.03	390.13	499.2	540.18	557.81
Raw Material	286.27	300.56	345.95	400.88	416.33
Increase Decrease in Cost	15.52	-29.19	12.62	1.06	-5.36
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	37.16	43.27	49.95	52.28	54.54
Miscellaneous Expenses	112.72	81.95	139.36	98.02	92.3
Operating Profit	81.78	87.39	51.79	74.41	78.19
Other Income	17.99	10.6	3.06	14.61	15.73
Depreciation	10.19	11.1	12.71	12.89	14.58
Interest	6.24	5.12	6.08	8.59	9.24
Profit before tax and exceptio..	83.34	81.78	36.07	67.54	70.1
Exceptional Items	0	0	0	0	0
PBT	83.34	81.78	36.07	67.54	70.1
Provision for Taxation	21.73	20.75	8.83	16.59	17.17
Net Profit	61.61	61.03	27.23	50.96	52.89
NET Profit after MI	61.61	61.03	27.23	50.96	52.89
EPS	14.24	13.77	5.65	10.57	10.97
Operating Profit Margin (%)	16.63	18.3	9.4	12.11	12.29
Net Profit Margin (%)	12.53	12.78	4.94	8.29	8.32

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	44.50	44.50	44.50	44.50	44.50
FII	1.30	0.70	0.80	0.50	0.40
MF	0.00	0.00	0.90	0.00	0.20
Public	54.00	54.70	53.50	54.90	54.80
Others	0.00	0.00	0.00	0.00	0.00
Others	0.20	0.10	0.30	0.10	0.10